Webinars & e-learning courses All webinars

Canine Lymphoma: not all lymphomas are created equal

Canine Lymphoma: not all lymphomas are created equal
Canine Lymphoma: not all lymphomas are created equal

There are many faces of canine lymphoma, and outcomes and treatments are not all the same. This webinar covers when to use molecular diagnostic tests in those tricky cases, and how to manage the different versions of canine lymphoma appropriately for the best possible outcome.

Recording from 05.06.2019

Speaker:

SandraNguyen-pic.jpg

Sandra Nguyen

Sandra Barnard-Nguyen BVSc (Hons I), Dip ACVIM (Onc)

Dr. Sandra Nguyen graduated from the University of Sydney and worked in small animal practice in Sydney before going onto her residency in Oncology at Cornell University in the USA. After a few years on faculty at the Ohio State University, Sandra returned to Australia and now works at SASH in Sydney and the Central Coast. She loves Oncology, Communication and People. 

Booking information

Duration: 0:40 h
Speaker: Sandra Nguyen
from 1
54.90 US$
(incl. tax)

You might also be interested in

canine-mast-cell-tumors-1.jpeg
Evi Pecceu
0:43 h

Canine Mast Cell Tumours

Canine mast cell tumours are common in general practice. The diagnosis is usually straightforward by means of fine needle aspiration; however, management can be challenging due to the variable behaviour ranging from locally infiltrating lesions to aggressive mast cell tumours metastasising to the liver and spleen. As a consequence, outcomes range from weeks to years. The aim of the webinar is to focus on the use of prognostic factors to predict the behaviour of mast cell tumours and to guide management of each individual case. Once the extent of disease and likely prognosis has been established, a plethora of treatment options need to be considered including surgery, radiation therapy, chemotherapy, targeted therapy, palliative supportive care as sole or multi-modal therapy. Dogs with a good prognosis should be offered treatment options aimed at long term control, whereas the focus for dogs with a poor prognosis might need to be palliative. The second part of the webinar is focused on highlighting when to consider which treatment options.
staging-the-oncology-patient.png
Laura Brockley
0:57 h

Staging the Oncology Patient

Staging is one of the most important components of oncology case management. It involves determining the extent of local disease along with the presence or absence of regional or distant metastasis. The results of staging are used to give more accurate and informed treatment options along with prognostic information for each oncology patient. Some of the biggest challenges in staging is to consider how much staging is required for each case, which are the most appropriate tests, and if the results of these tests will impact treatment options and prognosis. I will discuss this information in a case-based and evidence-based approach, focusing on some of the more common cancers including canine mast cell tumours, lymphoma, oral tumours and apocrine gland anal sac adenocarcinomas.
lumbectomies 300x200.png
Barney Dean
1:07 h

Don't Get Stumped by Lumps - Approaching Tricky Lumpectomies 

This webinar will discuss the rationale behind sound investigation and management of tricky mass removals, and how to adapt a plan to suit owner circumstances.